Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Spectral AI (MDAIW) Change in Account Payables (2022 - 2026)

Spectral AI posted quarterly Change in Account Payables of -$1.6 million for Q1 2026, down 67.69% year-on-year from -$4.9 million in Q1 2025, and down 436.44% on a QoQ basis from $472000.0 in Q4 2025.

Spectral AI (MDAIW) has 5 years of Change in Account Payables data on file, last reported at -$1.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 67.69% year-over-year to -$1.6 million; the trailing twelve-month figure through Mar 2026 stood at -$1.7 million (down 664.22% YoY), and the FY2025 full-year result was -$1.0 million, down 171.88% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$1.6 million, down from $472000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.2 million in Q4 2024 and bottomed at -$1.6 million in Q1 2026.
  • The 5-year median for Change in Account Payables is $93500.0 (2023), against an average of -$118785.7.
  • Peak annual rise in Change in Account Payables reached 424.93% in 2024, while the deepest fall reached 8109.09% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at $459000.0 in 2022, then slumped by 183.01% to -$381000.0 in 2023, then jumped by 424.93% to $1.2 million in 2024, then plunged by 61.87% to $472000.0 in 2025, then slumped by 436.44% to -$1.6 million in 2026.
  • The last three Change in Account Payables figures came in at -$1.6 million (Q1 2026), $472000.0 (Q4 2025), and $552000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -198.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 221.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 56.90 Mn
10 Spectral AI - - 2.03 Mn -1.59 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.59 Mn
Mar 31, 2026 -1.59 Mn
Dec 31, 2025 472,000.00
Dec 31, 2025 472,000.00
Sep 30, 2025 552,000.00
Sep 30, 2025 552,000.00
Jun 30, 2025 -1.10 Mn
Jun 30, 2025 -1.10 Mn
Mar 31, 2025 -947,000.00
Mar 31, 2025 -947,000.00
Dec 31, 2024 1.24 Mn
Dec 31, 2024 1.24 Mn
Sep 30, 2024 394,000.00
Sep 30, 2024 394,000.00
Jun 30, 2024 -903,000.00
Jun 30, 2024 -903,000.00
Mar 31, 2024 697,000.00
Mar 31, 2024 697,000.00
Dec 31, 2023 -381,000.00
Dec 31, 2023 -381,000.00
Sep 30, 2023 198,000.00
Sep 30, 2023 198,000.00
Jun 30, 2023 -11,000.00
Jun 30, 2023 -11,000.00
Mar 31, 2023 -741,000.00
Mar 31, 2023 -741,000.00
Dec 31, 2022 459,000.00
Dec 31, 2022 459,000.00